These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 2889492

  • 1. Antisecretory and antiulcer effect of the H2-receptor antagonist famotidine in the rat: comparison with ranitidine.
    Scarpignato C, Tramacere R, Zappia L.
    Br J Pharmacol; 1987 Sep; 92(1):153-9. PubMed ID: 2889492
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
    Reeves JJ, Stables R.
    Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
    [Abstract] [Full Text] [Related]

  • 4. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
    Muramatsu M, Isobe Y, Arai I, Hirose-Kijima H, Usuki-Ito C, Nagai H, Aihara H, Otomo S.
    Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
    Borella L, Russell J, Rimele TJ, Grimes D, Failli A, Mir GN.
    Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
    Sekiguchi H, Hamada K, Taga F, Nishino K.
    Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effect of famotidine on cat gastric secretion.
    Coruzzi G, Bertaccini G, Noci MT, Dobrilla G.
    Agents Actions; 1986 Nov; 19(3-4):188-93. PubMed ID: 2881456
    [Abstract] [Full Text] [Related]

  • 12. Effect of H2-receptor blockade on gastric mucus composition. A comparative study with ranitidine and famotidine.
    Guslandi M, Testoni PA, Masci E.
    J Int Med Res; 1987 Nov; 15(4):224-6. PubMed ID: 2888693
    [Abstract] [Full Text] [Related]

  • 13. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
    Makovec F, Revel L, Letari O, Mennuni L, Impicciatore M.
    Eur J Pharmacol; 1999 Mar 12; 369(1):81-90. PubMed ID: 10204685
    [Abstract] [Full Text] [Related]

  • 14. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
    Nishida A, Takinami Y, Yuki H, Kobayashi A, Akuzawa S, Kamato T, Ito H, Yamano M, Nagakura Y, Miyata K.
    J Pharmacol Exp Ther; 1994 Sep 12; 270(3):1256-61. PubMed ID: 7932178
    [Abstract] [Full Text] [Related]

  • 15. Acute effects of ranitidine, famotidine and omeprazole on plasma gastrin in the rat.
    Decktor DL, Pendleton RG, Kellner AT, Davis MA.
    J Pharmacol Exp Ther; 1989 Apr 12; 249(1):1-5. PubMed ID: 2565384
    [Abstract] [Full Text] [Related]

  • 16. [Effect of a new H2 receptor antagonist, famotidine, on gastric secretion].
    Noci MT, Coruzzi G.
    Boll Soc Ital Biol Sper; 1986 Sep 30; 62(9):1103-9. PubMed ID: 2879549
    [No Abstract] [Full Text] [Related]

  • 17. Gastric antisecretory and antiulcer activity of oxytocin in rats and guinea pigs.
    Asad M, Shewade DG, Koumaravelou K, Abraham BK, Vasu S, Ramaswamy S.
    Life Sci; 2001 Nov 21; 70(1):17-24. PubMed ID: 11764003
    [Abstract] [Full Text] [Related]

  • 18. Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats.
    Kinoshita M, Saito N, Tamaki H.
    Eur J Pharmacol; 1997 Mar 05; 321(3):325-32. PubMed ID: 9085044
    [Abstract] [Full Text] [Related]

  • 19. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
    Roszkowski AP, Garay GL, Baker S, Schuler M, Carter H.
    J Pharmacol Exp Ther; 1986 Nov 05; 239(2):382-9. PubMed ID: 3095537
    [Abstract] [Full Text] [Related]

  • 20. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K, Kato S, Yamamoto H, Okabe S.
    Arzneimittelforschung; 1996 Feb 05; 46(2):177-84. PubMed ID: 8720310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.